Article

Research facility: JDRF opens center for diabetic retinopathy

Hershey, PA-The Juvenile Diabetes Research Foundation (JDRF) has launched a $6.3-million Center for Mechanisms and Intervention of Diabetic Retinopathy at Penn State Milton S. Hershey Medical Center.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Cranial nerve six palsy with chemosis is a critical clue to cavernous carotid fistula
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
(Image credit: Ophthalmology Times) World Cornea Congress IX: Epi-on and accelerated crosslinking with Kenneth Beckman, MD
(Image credit: Ophthalmology Times) The synergy of cornea, cataract, and refractive surgery through the decades: insights from George O. Waring IV, MD
Related Content
(Image credit: AdobeStock/suphamit)
April 9th 2025

Novel multistage model enhances OCT GA segmentation

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

Relationship between fasting C-peptide and diabetic retinopathy in patients with type 2 diabetes mellitus
April 9th 2025

Relationship between fasting C-peptide and diabetic retinopathy in patients with type 2 diabetes mellitus

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

Opus Genetics reports 1-month pediatric results in gene therapy for inherited retinal disease
April 8th 2025

Opus Genetics reports 1-month pediatric results in gene therapy for inherited retinal disease

Tenpoint Therapeutics submits NDA application to FDA for BRIMOCHOL PF for the treatment of presbyopia
April 8th 2025

Tenpoint Therapeutics submits NDA application to FDA for BRIMOCHOL PF for the treatment of presbyopia

© 2025 MJH Life Sciences

All rights reserved.